|
|
|
|
| LEADER |
01098nam a2200289 i 4500 |
| 001 |
NSK01000920563 |
| 003 |
HR-ZaNSK |
| 005 |
20160112164722.0 |
| 007 |
ta |
| 008 |
151216s2010 vp d 001 0 eng |
| 020 |
|
|
|a 9781607611776
|
| 035 |
|
|
|a (HR-ZaNSK)000920563
|
| 040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
| 080 |
1 |
|
|a 576.36
|2 MRF 2011.
|
| 080 |
1 |
|
|a 615.2:616-006
|2 MRF 2011.
|
| 245 |
0 |
0 |
|a Checkpoint controls and targets in cancer therapy /
|c edited by Zahid H. Siddik.
|
| 260 |
|
|
|a Dordrecht [etc.] :
|b Humana Press,
|c cop. 2010.
|
| 300 |
|
|
|a XIV, 273 str. :
|b graf. prikazi (djelomice u bojama) ;
|c 26 cm.
|
| 490 |
0 |
|
|a Cancer drug discovery and development series
|
| 504 |
|
|
|a Bibliografija uz svaki rad.
|
| 504 |
|
|
|a Kazalo.
|
| 650 |
|
7 |
|a Stanični ciklus
|x Regulacija
|2 nskps
|
| 650 |
|
7 |
|a Antineoplastični lijekovi
|2 nskps
|
| 700 |
1 |
|
|a Siddik, Zahid H.
|4 edt
|
| 760 |
1 |
8 |
|t Cancer drug discovery and development series
|w nsk.(HR-ZaNSK)000864256
|
| 998 |
|
|
|m vhok1512
|c ktuo160112
|
| 856 |
4 |
1 |
|u http://dx.doi.org/10.1007/978-1-60761-178-3
|y Checkpoint controls and targets in cancer therapy
|
